Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Organ Transplantation Immunosuppressive Drug market report explains the definition, types, applications, major countries, and major players of the Organ Transplantation Immunosuppressive Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
GlaxoSmithKline plc
Sanofi SA
Novartis AG
Veloxis Pharmaceuticals A/S
AbbVie Inc
Allergan Plc
Bristol-Myers Squibb Company
Astellas Pharma Inc
Pfizer Inc
Roche
By Type:
Calcineurin Inhibitors
Antiproliferative Agents
mTOR Inhibitors
Antibodies
Steroids
By End-User:
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lungs Transplant
Others Transplant
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Organ Transplantation Immunosuppressive Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Organ Transplantation Immunosuppressive Drug Outlook to 2028- Original Forecasts
-
2.2 Organ Transplantation Immunosuppressive Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Organ Transplantation Immunosuppressive Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Organ Transplantation Immunosuppressive Drug Market- Recent Developments
-
6.1 Organ Transplantation Immunosuppressive Drug Market News and Developments
-
6.2 Organ Transplantation Immunosuppressive Drug Market Deals Landscape
7 Organ Transplantation Immunosuppressive Drug Raw Materials and Cost Structure Analysis
-
7.1 Organ Transplantation Immunosuppressive Drug Key Raw Materials
-
7.2 Organ Transplantation Immunosuppressive Drug Price Trend of Key Raw Materials
-
7.3 Organ Transplantation Immunosuppressive Drug Key Suppliers of Raw Materials
-
7.4 Organ Transplantation Immunosuppressive Drug Market Concentration Rate of Raw Materials
-
7.5 Organ Transplantation Immunosuppressive Drug Cost Structure Analysis
-
7.5.1 Organ Transplantation Immunosuppressive Drug Raw Materials Analysis
-
7.5.2 Organ Transplantation Immunosuppressive Drug Labor Cost Analysis
-
7.5.3 Organ Transplantation Immunosuppressive Drug Manufacturing Expenses Analysis
8 Global Organ Transplantation Immunosuppressive Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Organ Transplantation Immunosuppressive Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Organ Transplantation Immunosuppressive Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Organ Transplantation Immunosuppressive Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Calcineurin Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antiproliferative Agents Consumption and Growth Rate (2017-2022)
-
9.1.3 Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Steroids Consumption and Growth Rate (2017-2022)
-
9.2 Global Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Kidney Transplant Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Bone Marrow Transplant Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Liver Transplant Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Heart Transplant Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Lungs Transplant Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Transplant Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Organ Transplantation Immunosuppressive Drug Market Analysis and Outlook till 2022
-
10.1 Global Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.2.2 Canada Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.2.3 Mexico Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.2 UK Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.3 Spain Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.4 Belgium Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.5 France Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.6 Italy Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.7 Denmark Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.8 Finland Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.9 Norway Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.10 Sweden Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.11 Poland Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.12 Russia Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.3.13 Turkey Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.2 Japan Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.3 India Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.4 South Korea Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.5 Pakistan Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.7 Indonesia Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.8 Thailand Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.9 Singapore Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.10 Malaysia Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.11 Philippines Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.4.12 Vietnam Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.5.2 Colombia Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.5.3 Chile Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.5.4 Argentina Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.5.5 Venezuela Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.5.6 Peru Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.5.8 Ecuador Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.6.2 Kuwait Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.6.3 Oman Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.6.4 Qatar Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.7.2 South Africa Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.7.3 Egypt Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.7.4 Algeria Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
-
10.8.2 New Zealand Organ Transplantation Immunosuppressive Drug Consumption (2017-2022)
11 Global Organ Transplantation Immunosuppressive Drug Competitive Analysis
-
11.1 GlaxoSmithKline plc
-
11.1.1 GlaxoSmithKline plc Company Details
-
11.1.2 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
11.1.4 GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Sanofi SA
-
11.2.1 Sanofi SA Company Details
-
11.2.2 Sanofi SA Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Sanofi SA Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
11.2.4 Sanofi SA Organ Transplantation Immunosuppressive Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Novartis AG
-
11.3.1 Novartis AG Company Details
-
11.3.2 Novartis AG Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Novartis AG Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
11.3.4 Novartis AG Organ Transplantation Immunosuppressive Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Veloxis Pharmaceuticals A/S
-
11.4.1 Veloxis Pharmaceuticals A/S Company Details
-
11.4.2 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
11.4.4 Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 AbbVie Inc
-
11.5.1 AbbVie Inc Company Details
-
11.5.2 AbbVie Inc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 AbbVie Inc Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
11.5.4 AbbVie Inc Organ Transplantation Immunosuppressive Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Allergan Plc
-
11.6.1 Allergan Plc Company Details
-
11.6.2 Allergan Plc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Allergan Plc Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
11.6.4 Allergan Plc Organ Transplantation Immunosuppressive Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Bristol-Myers Squibb Company
-
11.7.1 Bristol-Myers Squibb Company Company Details
-
11.7.2 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
11.7.4 Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Astellas Pharma Inc
-
11.8.1 Astellas Pharma Inc Company Details
-
11.8.2 Astellas Pharma Inc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Astellas Pharma Inc Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
11.8.4 Astellas Pharma Inc Organ Transplantation Immunosuppressive Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Pfizer Inc
-
11.9.1 Pfizer Inc Company Details
-
11.9.2 Pfizer Inc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Pfizer Inc Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
11.9.4 Pfizer Inc Organ Transplantation Immunosuppressive Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Roche
-
11.10.1 Roche Company Details
-
11.10.2 Roche Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Roche Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
11.10.4 Roche Organ Transplantation Immunosuppressive Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Organ Transplantation Immunosuppressive Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Calcineurin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Antiproliferative Agents Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Steroids Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Kidney Transplant Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Bone Marrow Transplant Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Liver Transplant Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Heart Transplant Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Lungs Transplant Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Others Transplant Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Organ Transplantation Immunosuppressive Drug Market Analysis and Outlook to 2028
-
13.1 Global Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.5 France Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.3 India Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Organ Transplantation Immunosuppressive Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Organ Transplantation Immunosuppressive Drug
-
Figure of Organ Transplantation Immunosuppressive Drug Picture
-
Table Global Organ Transplantation Immunosuppressive Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Organ Transplantation Immunosuppressive Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Calcineurin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Antiproliferative Agents Consumption and Growth Rate (2017-2022)
-
Figure Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Steroids Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Marrow Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Heart Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Lungs Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Others Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Organ Transplantation Immunosuppressive Drug Consumption by Country (2017-2022)
-
Table North America Organ Transplantation Immunosuppressive Drug Consumption by Country (2017-2022)
-
Figure United States Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Organ Transplantation Immunosuppressive Drug Consumption by Country (2017-2022)
-
Figure Germany Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure France Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Organ Transplantation Immunosuppressive Drug Consumption by Country (2017-2022)
-
Figure China Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure India Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Table South America Organ Transplantation Immunosuppressive Drug Consumption by Country (2017-2022)
-
Figure Brazil Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Organ Transplantation Immunosuppressive Drug Consumption by Country (2017-2022)
-
Figure Bahrain Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Organ Transplantation Immunosuppressive Drug Consumption by Country (2017-2022)
-
Figure Nigeria Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Organ Transplantation Immunosuppressive Drug Consumption by Country (2017-2022)
-
Figure Australia Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Organ Transplantation Immunosuppressive Drug Consumption and Growth Rate (2017-2022)
-
Table GlaxoSmithKline plc Company Details
-
Table GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
Table GlaxoSmithKline plc Organ Transplantation Immunosuppressive Drug Product Portfolio
-
Table Sanofi SA Company Details
-
Table Sanofi SA Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
Table Sanofi SA Organ Transplantation Immunosuppressive Drug Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
Table Novartis AG Organ Transplantation Immunosuppressive Drug Product Portfolio
-
Table Veloxis Pharmaceuticals A/S Company Details
-
Table Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
Table Veloxis Pharmaceuticals A/S Organ Transplantation Immunosuppressive Drug Product Portfolio
-
Table AbbVie Inc Company Details
-
Table AbbVie Inc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Inc Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
Table AbbVie Inc Organ Transplantation Immunosuppressive Drug Product Portfolio
-
Table Allergan Plc Company Details
-
Table Allergan Plc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Plc Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
Table Allergan Plc Organ Transplantation Immunosuppressive Drug Product Portfolio
-
Table Bristol-Myers Squibb Company Company Details
-
Table Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
Table Bristol-Myers Squibb Company Organ Transplantation Immunosuppressive Drug Product Portfolio
-
Table Astellas Pharma Inc Company Details
-
Table Astellas Pharma Inc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
Table Astellas Pharma Inc Organ Transplantation Immunosuppressive Drug Product Portfolio
-
Table Pfizer Inc Company Details
-
Table Pfizer Inc Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
Table Pfizer Inc Organ Transplantation Immunosuppressive Drug Product Portfolio
-
Table Roche Company Details
-
Table Roche Organ Transplantation Immunosuppressive Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Organ Transplantation Immunosuppressive Drug Main Business and Markets Served
-
Table Roche Organ Transplantation Immunosuppressive Drug Product Portfolio
-
Figure Global Calcineurin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiproliferative Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Steroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone Marrow Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Heart Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lungs Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Organ Transplantation Immunosuppressive Drug Consumption Forecast by Country (2022-2028)
-
Table North America Organ Transplantation Immunosuppressive Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Organ Transplantation Immunosuppressive Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Organ Transplantation Immunosuppressive Drug Consumption Forecast by Country (2022-2028)
-
Figure China Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Organ Transplantation Immunosuppressive Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Organ Transplantation Immunosuppressive Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Organ Transplantation Immunosuppressive Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Organ Transplantation Immunosuppressive Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Organ Transplantation Immunosuppressive Drug Consumption Forecast and Growth Rate (2022-2028)
-
